Vontobel Holding Ltd. Invests $90,000 in Myomo, Inc. (NYSEAMERICAN:MYO)

Vontobel Holding Ltd. purchased a new stake in shares of Myomo, Inc. (NYSEAMERICAN:MYO) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 22,452 shares of the company’s stock, valued at approximately $90,000. Vontobel Holding Ltd. owned about 0.07% of Myomo at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Essex Investment Management Co. LLC grew its stake in shares of Myomo by 40.2% in the 3rd quarter. Essex Investment Management Co. LLC now owns 899,135 shares of the company’s stock worth $3,606,000 after buying an additional 257,749 shares in the last quarter. Herr Investment Group LLC increased its stake in Myomo by 72.9% during the second quarter. Herr Investment Group LLC now owns 2,846,071 shares of the company’s stock worth $9,136,000 after acquiring an additional 1,200,244 shares during the last quarter. AIGH Capital Management LLC raised its position in Myomo by 4.1% during the second quarter. AIGH Capital Management LLC now owns 2,917,997 shares of the company’s stock valued at $9,367,000 after purchasing an additional 115,405 shares during the period. Bailard Inc. bought a new stake in shares of Myomo in the 2nd quarter valued at approximately $109,000. Finally, Accel Wealth Management boosted its holdings in shares of Myomo by 6.0% in the 2nd quarter. Accel Wealth Management now owns 43,882 shares of the company’s stock worth $141,000 after purchasing an additional 2,500 shares during the period. Hedge funds and other institutional investors own 44.99% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on MYO. Lake Street Capital raised their price target on Myomo from $7.00 to $7.50 and gave the stock a “buy” rating in a research report on Tuesday, July 9th. HC Wainwright raised their target price on shares of Myomo from $6.50 to $7.50 and gave the stock a “buy” rating in a report on Monday, August 12th. Ascendiant Capital Markets lifted their price target on shares of Myomo from $8.25 to $8.50 and gave the stock a “buy” rating in a research note on Monday, August 19th. Finally, Craig Hallum began coverage on shares of Myomo in a research report on Wednesday, July 31st. They issued a “buy” rating and a $7.00 price objective on the stock.

Myomo Stock Up 0.5 %

NYSEAMERICAN:MYO opened at $3.75 on Thursday. The firm has a market cap of $113.36 million, a PE ratio of -14.42 and a beta of 1.54. Myomo, Inc. has a twelve month low of $1.06 and a twelve month high of $5.64.

Myomo (NYSEAMERICAN:MYO) last announced its quarterly earnings data on Tuesday, August 6th. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.04. The company had revenue of $7.52 million during the quarter, compared to analyst estimates of $7.30 million. Myomo had a negative net margin of 44.75% and a negative return on equity of 93.10%. On average, sell-side analysts anticipate that Myomo, Inc. will post -0.17 earnings per share for the current year.

Myomo Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.